Whole tumor section quantitative image analysis maximizes between-pathologists' reproducibility for clinical immunohistochemistry-based biomarkers
- PMID: 28805805
- DOI: 10.1038/labinvest.2017.82
Whole tumor section quantitative image analysis maximizes between-pathologists' reproducibility for clinical immunohistochemistry-based biomarkers
Abstract
Pathologists have had increasing responsibility for quantitating immunohistochemistry (IHC) biomarkers with the expectation of high between-reader reproducibility due to clinical decision-making especially for patient therapy. Digital imaging-based quantitation of IHC clinical slides offers a potential aid for improvement; however, its clinical adoption is limited potentially due to a conventional field-of-view annotation approach. In this study, we implemented a novel solely morphology-based whole tumor section annotation strategy to maximize image analysis quantitation results between readers. We first compare the field-of-view image analysis annotation approach to digital and manual-based modalities across multiple clinical studies (~120 cases per study) and biomarkers (ER, PR, HER2, Ki-67, and p53 IHC) and then compare a subset of the same cases (~40 cases each from the ER, PR, HER2, and Ki-67 studies) using whole tumor section annotation approach to understand incremental value of all modalities. Between-reader results for each biomarker in relation to conventional scoring modalities showed similar concordance as manual read: ER field-of-view image analysis: 95.3% (95% CI 92.0-98.2%) vs digital read: 92.0% (87.8-95.8%) vs manual read: 94.9% (91.4-97.8%); PR field-of-view image analysis: 94.1% (90.3-97.2%) vs digital read: 94.0% (90.2-97.1%) vs manual read: 94.4% (90.9-97.2%); Ki-67 field-of-view image analysis: 86.8% (82.1-91.4%) vs digital read: 76.6% (70.9-82.2%) vs manual read: 85.6% (80.4-90.4%); p53 field-of-view image analysis: 81.7% (76.4-86.8%) vs digital read: 80.6% (75.0-86.0%) vs manual read: 78.8% (72.2-83.3%); and HER2 field-of-view image analysis: 93.8% (90.0-97.2%) vs digital read: 91.0 (86.6-94.9%) vs manual read: 87.2% (82.1-91.9%). Subset implementation and analysis on the same cases using whole tumor section image analysis approach showed significant improvement between pathologists over field-of-view image analysis and manual read (HER2 100% (97-100%), P=0.013 field-of-view image analysis and 0.013 manual read; Ki-67 100% (96.9-100%), P=0.040 and 0.012; ER 98.3% (94.1-99.5%), p=0.232 and 0.181; and PR 96.6% (91.5-98.7%), p=0.012 and 0.257). Overall, whole tumor section image analysis significantly improves between-pathologist's reproducibility and is the optimal approach for clinical-based image analysis algorithms.
Similar articles
-
Effects of tissue decalcification on the quantification of breast cancer biomarkers by digital image analysis.Diagn Pathol. 2014 Nov 25;9:213. doi: 10.1186/s13000-014-0213-9. Diagn Pathol. 2014. PMID: 25421113 Free PMC article.
-
Cytokeratin-Supervised Deep Learning for Automatic Recognition of Epithelial Cells in Breast Cancers Stained for ER, PR, and Ki-67.IEEE Trans Med Imaging. 2020 Feb;39(2):534-542. doi: 10.1109/TMI.2019.2933656. Epub 2019 Aug 7. IEEE Trans Med Imaging. 2020. PMID: 31398111
-
Reading immunohistochemical slides on a computer monitor--a multisite performance study using 180 HER2-stained breast carcinomas.Appl Immunohistochem Mol Morphol. 2011 May;19(3):212-7. doi: 10.1097/PAI.0b013e3181f5e84d. Appl Immunohistochem Mol Morphol. 2011. PMID: 21475038
-
Ki-67 assessment of pancreatic neuroendocrine neoplasms: Systematic review and meta-analysis of manual vs. digital pathology scoring.Mod Pathol. 2022 Jun;35(6):712-720. doi: 10.1038/s41379-022-01055-1. Epub 2022 Mar 5. Mod Pathol. 2022. PMID: 35249100 Free PMC article. Review.
-
Multiplex Immunohistochemistry and Immunofluorescence: A Practical Update for Pathologists.Mod Pathol. 2023 Jul;36(7):100197. doi: 10.1016/j.modpat.2023.100197. Epub 2023 Apr 25. Mod Pathol. 2023. PMID: 37105494 Review.
Cited by
-
Atlas of PD-L1 for Pathologists: Indications, Scores, Diagnostic Platforms and Reporting Systems.J Pers Med. 2022 Jun 29;12(7):1073. doi: 10.3390/jpm12071073. J Pers Med. 2022. PMID: 35887569 Free PMC article. Review.
-
Novel approach to HER2 quantification using phosphor-integrated dots in human breast invasive cancer microarray.PLoS One. 2024 May 15;19(5):e0303614. doi: 10.1371/journal.pone.0303614. eCollection 2024. PLoS One. 2024. PMID: 38748758 Free PMC article.
-
Digital quantitative tissue image analysis of hypoxia in resected pancreatic ductal adenocarcinomas.Front Oncol. 2022 Aug 1;12:926497. doi: 10.3389/fonc.2022.926497. eCollection 2022. Front Oncol. 2022. PMID: 35978831 Free PMC article.
-
Development and applications of computer image analysis algorithms for scoring of PD-L1 immunohistochemistry.Immunooncol Technol. 2020 May 11;6:2-8. doi: 10.1016/j.iotech.2020.04.001. eCollection 2020 Jun. Immunooncol Technol. 2020. PMID: 35757235 Free PMC article. Review.
-
Association of artificial intelligence-powered and manual quantification of programmed death-ligand 1 (PD-L1) expression with outcomes in patients treated with nivolumab ± ipilimumab.Mod Pathol. 2022 Nov;35(11):1529-1539. doi: 10.1038/s41379-022-01119-2. Epub 2022 Jul 15. Mod Pathol. 2022. PMID: 35840720 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous